Actively Recruiting
The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception
Led by Medisch Spectrum Twente · Updated on 2024-11-25
39
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Asthma is a common childhood disease that is characterized by chronic airway inflammation and episodic expiratory airflow obstruction. Asthma symptoms can impair participation in play and sports and have a negative impact on quality of life. It can be challenging for children to adequately feel and report their symptoms. Some children experience more symptoms than expected based on lung function during these symptoms, whereas others experience less symptoms than expected. This is also called 'symptom perception'. A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool. Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.
CONDITIONS
Official Title
The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatrician diagnosed asthma
- Health care professional thinks perception might be poor
- Age 7 until 15 years old
- Adequate understanding of Dutch language
- At least 4 lung function measurements after exercise or symptoms and 2 standard measurements during selection phase
- Poor perception during selection phase defined by measurements in red, orange, or yellow zones on the Perception Rainbow tool
You will not qualify if you...
- Severe comorbidity such as psychomotor retardation or severe cardiopulmonary conditions
- Unable to fill in VAS score (e.g., due to blindness)
- Unable to perform correct spirometry maneuvers
- Medication change in past 2 weeks
- Exacerbation requiring oral prednisone in past 6 weeks
- Exacerbation at time of inclusion
- No device with internet connection available at home
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands, 7512 KZ
Actively Recruiting
Research Team
V
Vera Hengeveld, MD
CONTACT
M
Mattienne van der Kamp, MSc, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here